Press Releases

 
Press Releases
  Date Title View
May 18, 2016
First quarter 2016 HIFU Division revenue increased 102% year-over-year37% growth in HIFU treatment driven revenues in Q1 2016 compared to Q1 2015€0.7 million operating profit, €1.4 million net income in first quarter 2016510(k) application for Focal One submitted to FDA LYON, France, May 18, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA ...
May 10, 2016
LYON, France, May 10, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it plans to release financial results for the first quarter ended March 31, 2016, on May 18, 2016, during pre-market hours.     Company management will host a conference call on Wednesday, May 18, 2016 at ...
May 4, 2016
Company to Participate in Two Plenary Sessions and Five Poster Sessions Ablatherm Treatments Performed During "L.A. Live" Pre-AUA Symposium at USCLYON, France, May 04, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that it will demonstrate the capabilities of the Ablatherm Robot...
Apr 28, 2016
LYON, France, April 28, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that The Brazilian Health Surveillance Agency (Anvisa) has approved Focal One for sale in Brazil. Marc Oczachowski, EDAP TMS Chief Executive Officer, commented: "This approval in Latin America's largest mar...
Apr 25, 2016
LYON, France, April 25, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the sale and installation of Ablatherm Robotic HIFU at Houston Methodist Hospital, Houston, Texas. The hospital is the first location in Texas to install EDAP's noninvasive HIFU device for the ablation of prosta...
Apr 18, 2016
LYON, France, April 18, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first prostate ablation treatments performed in Orlando, Florida, using the Company's FDA-cleared Ablatherm Robotic HIFU. This Ablatherm Robotic HIFU is owned by HIFU Solution, LLC who has mobilized the...
Apr 14, 2016
Positions EDAP to Accelerate U.S. Sales and Marketing Expansion for HIFU Strengthens Financial Resources to Grow Global Operations LYON, France, April 14, 2016 (GLOBE NEWSWIRE) --  EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, announced the closing of its previously announced $11.5 million registered direct placemen...
Apr 7, 2016
LYON, France, April 07, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, announced that it has entered into definitive agreements with certain institutional investors for a registered direct placement of 3,283,284 ordinary shares in the form of American Depositary Shares ("ADSs") at a price of $3.50 p...
Apr 6, 2016
LYON, France, April 06, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that it has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for the clearance of its next generation HIFU device: the Focal One®. This submission follows the November 2015 FDA ...
Apr 4, 2016
Obtained FDA clearance in November 2015 for Ablatherm Robotic HIFU;Fourth quarter 2015 HIFU Division revenues tripled over fourth quarter 2014;Overall fourth quarter 2015 revenues increased 82% over 2014 to EUR 11.8 million (USD 12.8 million);Solid cash position of EUR 14.6 million (USD 15.8 million) as of December 31, 2015;Strong momentum in U.S. ...
1
... NextLast
= add release to Briefcase